Position in NVCR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$18,666,117
+$7,958,470 QoQ
Shares Held
1,232,087
+25.4% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 217 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Nuveen, LLC holds $3,157,043,363 across 76 Medical Devices names. NVCR ranks #19 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
9,876,345 | $896,179,544 | |
| 2 | SYK |
Stryker Corp
|
1,505,533 | $474,002,008 | |
| 3 | BSX |
Boston Scientific Corp
|
8,695,119 | $371,107,677 | |
| 4 | EW |
Edwards Lifesciences Corp
|
2,960,468 | $267,803,933 | |
| 5 | MDT |
Medtronic plc
|
3,338,490 | $261,170,071 | |
| 6 | DXCM |
Dexcom Inc
|
1,830,235 | $123,266,325 | |
| 7 | STE |
STERIS plc
|
382,600 | $80,564,080 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
1,165,068 | $74,576,000 |
All Filings in NVCR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,666,117 | 1,232,087 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $10,707,647 | 982,353 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $16,464,401 | 1,273,349 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $22,065,317 | 1,707,842 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $18,270,596 | 1,026,438 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $12,362,945 | 693,768 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||